在GERD中P-CABs的作用
1Professor Emeritus, University of Tennessee College of Medicine, Memphis, Tennessee, USA .
The American journal of gastroenterology
|October 28, 2024
概括
竞争性酸阻断剂 (P-CABs) 提供了一种抑制胃酸的新方法. 本综述探讨了与质子抑制剂相比,它们的药理学和治疗胃食道逆流症的疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 药物开发 药物开发
背景情况:
- 竞争性酸阻断剂 (P-CABs) 是一类新的胃酸抑制剂.
- 诺普拉赞是第一个在美国获得批准的P-CAB,尽管其他药物自2014年以来已在国际上开放.
- 在药理上,P-CAB与传统的质子抑制剂 (PPI) 有着很大的区别.
研究的目的:
- 审查P-CABs和PPI之间的药理学区别.
- 评估P-CABs在管理各种形式的胃食道逆流病 (GERD) 中的作用.
- 分析临床试验数据,将P-CAB与PPI和安慰剂进行比较,用于治疗GERD.
主要方法:
- 对P-CABs和PPI药理性质的文献综述.
- 对涉及P-CABs用于侵蚀性食道炎和非侵蚀性反流性疾病的临床试验的系统审查.
- 对研究结果的分析,以推断在美国环境中的临床效用.
主要成果:
- 与PPI相比,P-CABs具有不同的药理学特征.
- 临床试验表明P-CABs在治疗侵蚀性食道炎和非侵蚀性反流性疾病中的有效性.
- 有证据表明P-CAB在更广泛的GERD管理中具有潜力.
结论:
- 由于其独特的药理学,P-CABs为GERD治疗提供了一个有希望的替代方案.
- 需要进一步的研究来探索P-CAB在GERD中的其他应用.
- 根据国际经验和试验数据,预计P-CABs在美国的临床采用.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
360
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
360
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
407
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
407
Gastroesophageal Reflux Disease II: Clinical Features and Management
55
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
55
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
330
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
330
Antihypertensive Drugs: Potassium-Sparing Diuretics
464
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
464
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74


